13F-HR filed by GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 29 holding rows worth $308,414,328.
- Accession
- 0001172661-26-001093
- Filer
- CIK 1281446
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 29 entries on the cover page, a total value of $308,414,328 stated on the cover page (in dollars after the unit check, H1), rows summing to $308,414,328 with VALUE read as dollars as filed, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJAY JEFFREY R028-12517
- included managerNordahl Lillian028-24470
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 374,000 | $28,229,520 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 1,750,000 | $21,140,000 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 3,815,930 | $19,995,473 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 250,000 | $19,852,500 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E208 | COM NEW | 581,187 | $19,684,804 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 750,000 | $19,065,000 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 400,000 | $18,520,000 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 1,370,107 | $17,921,000 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 350,000 | $14,423,500 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 806,273 | $12,440,792 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 685,632 | $11,072,957 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 800,000 | $9,144,000 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 1,200,000 | $9,060,000 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 800,000 | $9,048,000 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 210,732 | $8,909,749 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 300,000 | $8,145,000 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 350,000 | $7,210,000 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 300,000 | $6,900,000 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 4,683,711 | $6,885,055 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 634,032 | $6,562,231 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 325,000 | $5,564,000 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 183,330 | $5,556,732 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 808,032 | $4,912,835 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y202 | COMMON STOCK | 796,558 | $4,596,140 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 979,534 | $3,918,136 | dollars as filed | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 700,000 | $2,849,000 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 82,800 | $2,297,700 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 124,666 | $2,263,935 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 951,809 | $2,246,269 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-26-001093 | this filing | 2026-02-17 | acceptance time not in the bulk data set |